VHIBF
Vitalhub Corp.
OTC Markets OTCQXUSDEQUITY
Healthcare
DELAYED
Last price
5.80
■ 0.00 (0.00%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Tool
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
5.80
Prev close
5.80
Day high
5.80
Day low
5.80
Volume
100
Market cap
$367.37M
P/E (TTM)
64.44
52W range
4.57 – 9.89
Day trading desk
Gap from prior close
-0.00%
Prior close 5.80
VWAP
—
—
Relative volume
0.00×
Quiet session
Session range
—
5.80 – 5.80
Position in range
—
—
ATR (14D)
0.14
2.44% of price
Prior day high
5.80
PDH
Prior day low
5.80
PDL
Bid / ask spread
—
Quote not published
Session volume
—
Avg 14.52K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+2.47%
+3.8%
1M
+25.27%
+21.5%
3M
+13.73%
+10.6%
6M
-6.65%
-17.7%
YTD
-16.17%
-28.5%
1Y
-36.89%
-56.9%
3Y
—
-74.2%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on VHIBF open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
13.33M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Jun 26, 26 | Brett (Allan) Director of Issuer |
— | 0 | — | Direct |
| Jun 26, 26 | Shen (Andrew Anthony) Director of Issuer |
— | 0 | — | Direct |
| Jun 26, 26 | Shen (Andrew Anthony) Director of Issuer |
— | 0 | — | Indirect |
| Jun 26, 26 | Shen (Andrew Anthony) Director of Issuer |
— | 0 | — | Indirect |
| Jun 5, 26 | Garrington (Steve) Director of Issuer |
EXERCISE | 10.00K | $51.46K | Direct |
| Mar 30, 26 | Shen (Anthony Pius) Director of Issuer |
BUY | 7.00K | $35.75K | Indirect |
| Mar 26, 26 | Mazza (Patrick John) Senior Officer of Issuer |
BUY | 9.36K | $47.61K | Direct |
| Mar 26, 26 | Shen (Francis Nelson) Director of Issuer |
BUY | 50.00K | $252.20K | Indirect |
| Mar 24, 26 | Shen (Francis Nelson) Director of Issuer |
BUY | 439.60K | $2.24M | Indirect |
| Mar 23, 26 | Goffenberg, Brian Director or Senior Officer of 10% Security Holder |
GRANT | 1.60K | $8.16K | Direct |
| Mar 23, 26 | Matlow (Danny) Director or Senior Officer of 10% Security Holder |
GRANT | 3.20K | $16.32K | Direct |
| Mar 23, 26 | Mazza (Patrick John) Senior Officer of Issuer |
GRANT | 1.60K | $8.16K | Direct |
| Dec 23, 25 | Shen (Anthony Pius) Director of Issuer |
BUY | 5.47K | $36.89K | Indirect |
| Dec 23, 25 | Shen (Francis Nelson) Director of Issuer |
BUY | 148.70K | $983.35K | Indirect |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
Brett (Allan) |
Director of Issuer | 73.75K | Opening Balance-Initial SEDI Report |
Garrington (Steve) |
Director of Issuer | 70.00K | Exercise of options |
Goffenberg, Brian |
Director or Senior Officer of 10% Security Holder | 48.55K | Grant of options |
Matlow (Danny) |
Director or Senior Officer of 10% Security Holder | 86.56K | Grant of options |
Mazza (Patrick John) |
Senior Officer of Issuer | 50.38K | Acquisition or disposition in the public market |
Shen (Andrew Anthony) |
Director of Issuer | 55.60K | Opening Balance-Initial SEDI Report |
Shen (Anthony Pius) |
Director of Issuer | — | Acquisition or disposition in the public market |
Shen (Francis Nelson) |
Director of Issuer | — | Acquisition or disposition in the public market |
Fundamentals
Market cap$367.37M
Enterprise value$233.72M
Revenue (TTM)$127.08M
Gross profit$102.00M
EBITDA$25.15M
Net income$7.48M
EPS (TTM)$0.09
Free cash flow$32.28M
Total cash$136.51M
Total debt$2.86M
Book value / share$3.11
Shares outstanding63.34M
Float55.97M
Short % of float—
Dividend yield—
Beta (5Y)0.80
Valuation & profitability ratios
Trailing P/E64.44
Forward P/E—
PEG ratio3.28
Price / sales—
Price / book1.86
EV / revenue1.84
EV / EBITDA9.29
Gross margin80.26%
Operating margin13.73%
Profit margin5.89%
Return on equity3.28%
Return on assets2.90%
Debt / equity1.05
Current ratio2.15
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $108.97M | $68.59M | $52.51M | $39.97M | +58.9% |
| Operating revenue | $108.87M | $68.46M | $52.48M | $39.88M | +59.0% |
| Cost of revenue | $21.38M | $13.10M | $9.70M | $7.03M | +63.2% |
| Gross profit | $87.59M | $55.49M | $42.81M | $32.94M | +57.8% |
| Research & development | $28.95M | $15.23M | $12.17M | $10.43M | +90.1% |
| Selling, general & admin | $35.39M | $24.56M | $18.80M | $13.97M | +44.1% |
| Total operating expense | $75.42M | $45.75M | $35.95M | $28.28M | +64.8% |
| Operating income | $12.17M | $9.74M | $6.86M | $4.66M | +24.9% |
| Net interest income | $2.35M | $1.91M | $417.58K | -$70.34K | +23.1% |
| Pre-tax income | $5.90M | $5.90M | $5.33M | $1.31M | +0.1% |
| Tax provision | -$209.56K | $2.90M | $778.25K | $92.08K | -107.2% |
| Net income | $6.11M | $3.00M | $4.55M | $1.21M | +103.8% |
| Net income to common | $6.11M | $3.00M | $4.55M | $1.21M | +103.8% |
| Basic EPS | 0.10 | 0.06 | 0.11 | 0.03 | +66.7% |
| Diluted EPS | 0.10 | 0.06 | 0.10 | 0.03 | +66.7% |
| EBIT | $5.97M | $5.94M | $5.40M | $1.38M | +0.6% |
| EBITDA | $17.05M | $11.90M | $10.38M | $5.25M | +43.3% |
| Basic shares | 58.54M | 49.20M | 43.65M | 41.49M | +19.0% |
| Diluted shares | 60.29M | 50.93M | 46.60M | 42.56M | +18.4% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $57.63M | $56.57M | $33.48M | $17.45M | — | +1.9% |
| Cash & short-term investments | $119.18M | $56.57M | $33.48M | $17.45M | — | +110.7% |
| Accounts receivable | $17.89M | $15.13M | $8.38M | $10.12M | — | +18.3% |
| Inventory | $63.08K | $239.59K | $169.62K | $704.41K | — | -73.7% |
| Total current assets | $145.66M | $75.24M | $43.91M | $30.57M | — | +93.6% |
| Property, plant & equipment | $3.87M | $1.95M | $1.08M | $1.43M | — | +98.2% |
| Goodwill & intangibles | $201.91M | $128.47M | $73.76M | $74.19M | — | +57.2% |
| Total assets | $352.71M | $207.19M | $118.78M | $106.19M | — | +70.2% |
| Total current liabilities | $60.58M | $44.35M | $29.07M | $23.82M | — | +36.6% |
| Current debt | — | — | — | — | $29.16K | — |
| Total debt | $2.51M | $608.76K | $541.09K | $882.20K | — | +313.0% |
| Total liabilities | $86.78M | $62.33M | $36.88M | $30.79M | — | +39.2% |
| Retained earnings | $5.67M | -$445.72K | -$3.44M | -$8.44M | — | +1,371.0% |
| Shareholder equity | $265.93M | $144.86M | $81.91M | $75.40M | — | +83.6% |
| Working capital | $85.08M | $30.90M | $14.84M | $6.75M | — | +175.4% |
| Net tangible assets | $64.02M | $16.39M | $8.15M | $1.21M | — | +290.5% |
| Shares issued | 63.23M | 52.62M | 43.71M | 43.60M | — | +20.2% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Net income | $6.11M | $3.00M | $4.55M | $1.21M | — | +103.8% |
| Depreciation & amortisation | $11.08M | $5.96M | $4.98M | $3.87M | — | +85.8% |
| Stock-based compensation | $2.65M | $2.34M | $1.16M | $1.14M | — | +12.9% |
| Change in working capital | -$8.08M | $4.49M | $9.29M | -$997.91K | — | -280.0% |
| Operating cash flow | $8.32M | $15.13M | $20.47M | $6.12M | — | -45.0% |
| Capital expenditure | -$423.14K | -$883.72K | -$290.11K | -$295.05K | — | +52.1% |
| Investing cash flow | -$111.11M | -$31.39M | -$4.15M | -$21.84M | — | -254.0% |
| Share buybacks | — | $0 | -$39.07K | -$215.42K | $0 | — |
| Financing cash flow | $104.59M | $39.09M | -$287.89K | $16.40M | — | +167.6% |
| Free cash flow | $7.90M | $14.24M | $20.18M | $5.83M | — | -44.5% |
| End cash position | $57.63M | $56.57M | $33.48M | $17.45M | — | +1.9% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | $31.74M | $31.91M | $31.39M | $32.04M | $23.86M | — | -0.5% |
| Operating revenue | $31.69M | $31.89M | $31.36M | $32.02M | $23.84M | — | -0.6% |
| Cost of revenue | $6.57M | $5.86M | $6.49M | $6.16M | $4.50M | — | +12.1% |
| Gross profit | $25.17M | $26.04M | $24.90M | $25.88M | $19.36M | — | -3.4% |
| Research & development | $8.47M | $9.04M | $8.46M | $9.24M | $6.03M | — | -6.3% |
| Selling, general & admin | $8.78M | $9.25M | $9.20M | $10.02M | $8.11M | — | -5.0% |
| Total operating expense | $20.81M | $21.87M | $21.12M | $22.90M | $15.94M | — | -4.8% |
| Operating income | $4.36M | $4.18M | $3.79M | $2.98M | $3.42M | — | +4.3% |
| Net interest income | $632.08K | $653.63K | $922.85K | $455.24K | $449.64K | — | -3.3% |
| Pre-tax income | $3.64M | $3.60M | $750.09K | $1.41M | $2.26M | — | +1.2% |
| Tax provision | $1.69M | $1.25M | -$3.32M | $2.30M | $483.01K | — | +35.9% |
| Net income | $1.95M | $2.36M | $4.07M | -$890.26K | $1.77M | — | -17.2% |
| Net income to common | $1.95M | $2.36M | $4.07M | -$890.26K | $1.77M | — | -17.2% |
| Basic EPS | 0.03 | 0.04 | — | -0.01 | 0.03 | 0.02 | -25.0% |
| Diluted EPS | 0.03 | 0.04 | — | -0.01 | 0.03 | 0.02 | -25.0% |
| EBIT | $3.69M | $3.64M | $766.72K | $1.43M | $2.27M | — | +1.3% |
| EBITDA | $7.25M | $7.22M | $4.22M | $5.08M | $4.06M | — | +0.4% |
| Basic shares | 63.28M | 63.23M | — | 59.58M | 55.85M | 55.78M | +0.1% |
| Diluted shares | 64.50M | 64.82M | — | 61.47M | 57.91M | 55.78M | -0.5% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $70.52M | $40.60M | $57.63M | $123.68M | $94.01M | +73.7% |
| Cash & short-term investments | $136.51M | $121.27M | $119.18M | $123.68M | $94.01M | +12.6% |
| Accounts receivable | $32.31M | $35.23M | $17.89M | $15.98M | $16.90M | -8.3% |
| Inventory | $74.26K | $65.07K | $63.08K | $579.64K | $597.48K | +14.1% |
| Total current assets | $178.32M | $165.23M | $145.66M | $151.40M | $121.31M | +7.9% |
| Property, plant & equipment | $4.22M | $3.80M | $3.87M | $2.99M | $1.67M | +11.2% |
| Goodwill & intangibles | $197.94M | $199.12M | $201.91M | $212.66M | $151.23M | -0.6% |
| Total assets | $381.84M | $369.65M | $352.71M | $370.13M | $277.26M | +3.3% |
| Total current liabilities | $82.93M | $73.15M | $60.58M | $77.94M | $76.12M | +13.4% |
| Current debt | — | — | — | — | $15.00M | — |
| Total debt | $2.86M | $2.60M | $2.51M | $1.60M | $15.59M | +10.1% |
| Total liabilities | $107.63M | $100.23M | $86.78M | $108.24M | $94.93M | +7.4% |
| Retained earnings | $9.97M | $8.02M | $5.67M | $1.60M | $2.49M | +24.3% |
| Shareholder equity | $274.22M | $269.42M | $265.93M | $261.89M | $182.33M | +1.8% |
| Working capital | $95.39M | $92.08M | $85.08M | $73.46M | $45.18M | +3.6% |
| Net tangible assets | $76.28M | $70.30M | $64.02M | $49.23M | $31.10M | +8.5% |
| Shares issued | 63.26M | 63.26M | 63.23M | 63.12M | 56.08M | +0.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|---|
| Net income | $1.95M | $2.36M | $4.07M | -$890.26K | $1.77M | — | -17.2% |
| Depreciation & amortisation | $3.56M | $3.58M | $3.46M | $3.65M | $1.79M | — | -0.6% |
| Stock-based compensation | $470.18K | $469.76K | $500.28K | $647.32K | $734.81K | — | +0.1% |
| Change in working capital | $9.71M | -$4.36M | -$12.91M | $7.20M | -$1.36M | — | +322.8% |
| Operating cash flow | $15.95M | $2.32M | -$6.40M | $9.46M | $2.60M | — | +586.6% |
| Capital expenditure | -$302.54K | -$59.29K | -$118.42K | -$147.31K | -$84.81K | — | -410.3% |
| Investing cash flow | $14.09M | -$19.17M | -$59.95M | -$36.20M | -$14.88M | — | +173.5% |
| Share buybacks | — | — | — | — | — | $0 | — |
| Financing cash flow | $87.91K | -$33.16K | $310.98K | $56.35M | $15.76M | — | +365.1% |
| Free cash flow | $15.65M | $2.26M | -$6.51M | $9.31M | $2.51M | — | +591.2% |
| End cash position | $70.52M | $40.60M | $57.63M | $123.68M | $94.01M | — | +73.7% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $33.39M | +4.2% |
| Next quarter | — | — | $34.28M | +9.2% |
| Current year | — | — | $131.23M | +20.4% |
| Next year | — | — | $144.05M | +9.8% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders21.05%
Held by institutions25.79%
Institutions holding30
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
5.57
+4.05% from price
SMA 20
5.29
+9.56% from price
SMA 50
5.13
+13.10% from price
SMA 100
5.31
+9.28% from price
SMA 200
5.79
+0.24% from price
EMA 12
5.52
+4.99% from price
EMA 26
5.34
+8.65% from price
EMA 50
5.27
+10.16% from price
RSI (14)
68.5
Neutral
MACD (12,26,9)
0.19
Hist 0.06
ATR (14)
0.14
2.44% of price
Realised vol 30D
44.4%
Annualised
Bollinger upper
5.96
20, 2σ
Bollinger lower
4.63
20, 2σ
50 / 200 cross
Death
5.13 vs 5.79
Trend bias
Above 200
+0.24%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.83
Less volatile than market
Correlation to SPY
0.25
Largely independent
Realised vol 30D
44.4%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-53.4%
Peak to trough
Max drawdown 5Y
-55.1%
Peak to trough
ATR 14
0.14
2.44% of price
Beta (reported)
0.80
5Y monthly, from filing
Headlines
Vitalhub Q2 Earnings Call Highlights
MarketBeat · 13d ago
VitalHub Reports Second Quarter 2026 Results
GlobeNewswire · 17d ago
VitalHub Announces Normal Course Issuer Bid
GlobeNewswire · 17d ago
VitalHub Announces Q2 2026 Conference Call Date
GlobeNewswire · 25d ago
VitalHub Announces Acquisition of Buddy Healthcare
GlobeNewswire · 41d ago
VitalHub Announces Results of Annual General Meeting of Shareholders
GlobeNewswire · 58d ago
Vitalhub (TSX:VHI) Stock Faces Mixed Analyst Target Changes On Growth And Margin Revisions
Simply Wall St. · 67d ago
Vitalhub Unit Novari to Deploy Referral Management Software in Northern British Columbia
MT Newswires · 68d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.